Direct and synergistic hemolysis caused by Staphylococcus phenol-soluble modulins: implications for diagnosis and

Gordon Y C Cheung1, Anthony C Duong, Michael Otto

  • 1Pathogen Molecular Genetics Section, Laboratory of Human Bacterial Pathogenesis, National Institute of Allergy and Infectious Diseases, The National Institutes of Health, Bethesda, MD 20892, USA.

Microbes and Infection
|December 20, 2011
PubMed

Insights

Phenol-soluble modulin (PSM) peptides from Staphylococcus species lyse human red blood cells. Their hemolytic activity is enhanced by β-toxin, suggesting a broader role in staphylococcal infections.

Area of Science:

  • Microbiology
  • Molecular Biology
  • Pathogenesis

Background:

  • Phenol-soluble modulins (PSMs) are amphipathic α-helical peptides secreted by staphylococci.
  • Certain PSMs are potent cytolysins against human neutrophils, acting as key virulence factors in Staphylococcus aureus infections.
  • The hemolytic potential of PSMs against human erythrocytes remains largely unexplored.

Purpose of the Study:

  • To investigate the capacity of PSMs from S. aureus and Staphylococcus epidermidis to lyse human erythrocytes.
  • To determine if PSMs exhibit synergistic hemolytic activity with S. aureus β-toxin.
  • To elucidate the role of PSMs in staphylococcal pathogenesis and hemolysin diversity.

Main Methods:

  • Erythrolysis assays using purified PSMs from S. aureus and S. epidermidis.
  • Assessment of synergistic hemolysis between PSMs and purified S. aureus β-toxin.
  • CAMP assays utilizing the β-toxin-producing S. aureus strain RN4220.

Main Results:

  • Many S. aureus and S. epidermidis PSMs were found to lyse human erythrocytes.
  • Synergistic interactions between several PSMs and S. aureus β-toxin significantly enhanced hemolytic activity.
  • PSMα peptides, in particular, demonstrated substantial contribution to synergistic hemolysis.
  • CAMP assays indicated PSMs' role in synergistic hemolysis, not suitable for δ-toxin detection but useful for Agr functionality assessment.

Conclusions:

  • PSMs possess hemolytic activity against human erythrocytes, expanding their known pathogenic roles.
  • Synergism between PSMs and β-toxin is a significant factor in staphylococcal virulence, especially in mixed infections.
  • The diversity of staphylococcal hemolysins is greater than previously understood, with PSMs contributing significantly.

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Hypersensitivity Reactions: Cytolytic Reactions01:01

Hypersensitivity Reactions: Cytolytic Reactions

Type II hypersensitivity involves IgG and IgM antibodies targeting cell surface antigens, leading to cell destruction. This can occur through complement activation, antibody-dependent cell-mediated cytotoxicity (ADCC), or acting as opsonins for phagocytosis. When excessive, these reactions cause significant tissue damage.Drug-induced hemolytic anemia is a common example, where drugs like penicillin or cephalosporins bind to red blood cells, forming drug-protein complexes. These complexes...
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...